|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4725 | |
| A61K 31/14 | |||
| A61K 31/198 | |||
| A61K 31/277 | |||
| A61K 31/341 | |||
| A61K 31/343 | |||
| A61K 31/4025 | |||
| A61K 31/472 | |||
| A61K 31/381 | |||
| A61K 31/496 | |||
| A61K 31/502 | |||
| A61K 31/517 | |||
| A61K 31/66 | |||
| A61P 27/02 | |||
| A61K 45/06 | |||
| A61K 9/00 |
| (11) | Number of the document | 3167886 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16204718.7 |
| Date of filing the European patent application | 2008-10-17 | |
| (97) | Date of publication of the European application | 2017-05-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 999571 P | 2007-10-19 | US |
| (72) |
BURNIER, John, US
GADEK, Thomas, US
SEMBA, Charles, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMPOSITIONS AND METHODS FOR TREATMENT OF MACULAR EDEMA |
| COMPOSITIONS AND METHODS FOR TREATMENT OF MACULAR EDEMA |